Ralph S DaCosta
Fondateur chez Moleculight, Inc.
Profil
Ralph S DaCosta is the founder of Moleculight, Inc. which was founded in 2012, where he holds the title of Director & Chief Scientific Officer since 2012.
He is currently working as a Clinical & Technical Advisor at iGan Partners.
Dr. DaCosta obtained a doctorate degree from the University of Toronto.
Postes actifs de Ralph S DaCosta
| Sociétés | Poste | Début |
|---|---|---|
Moleculight, Inc.
 Moleculight, Inc. Medical SpecialtiesHealth Technology Moleculight, Inc. operates as a medical imaging company delivering fluorescence image-guidance solutions that provide clinicians with new information about wound bacterial burden for better diagnostic and treatment decisions. Its products include Moleculight i:X and DarkDrape. The company was founded by Ralph S. DaCosta in June 1, 2012 and is headquartered in Toronto, Canada. | Fondateur | 01/01/2012 |
iGan Partners
 iGan Partners Investment ManagersFinance iGan Partners (iGan Partners) is a venture capital firm founded in 2010 by Sam Ifergan. The firm is headquartered in Toronto, Canada. | Consultant / Advisor | - |
Formation de Ralph S DaCosta
| University of Toronto | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Moleculight, Inc.
Moleculight, Inc. Medical SpecialtiesHealth Technology Moleculight, Inc. operates as a medical imaging company delivering fluorescence image-guidance solutions that provide clinicians with new information about wound bacterial burden for better diagnostic and treatment decisions. Its products include Moleculight i:X and DarkDrape. The company was founded by Ralph S. DaCosta in June 1, 2012 and is headquartered in Toronto, Canada. | Health Technology |
iGan Partners
iGan Partners Investment ManagersFinance iGan Partners (iGan Partners) is a venture capital firm founded in 2010 by Sam Ifergan. The firm is headquartered in Toronto, Canada. | Finance |